Developing a targeted therapy for alcohol use disorder based on an approved drug.
Industry: Health Care
First Day Return: -19.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/07/2017 |
Offer Price | $5.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 1.5 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/26/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Charlottesville, VA, United States |
Founded | 2010 |
Employees at IPO | 3 |
Website www.adialpharma.com |